XML 33 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2017
USD ($)
Plan
$ / shares
shares
Mar. 31, 2016
USD ($)
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Share-based Compensation [Abstract]      
Number of stock based compensation plans | Plan 1    
Additional Disclosures [Abstract]      
Proceeds from stock option exercises $ 258,250 $ 177,250  
Closing price of common stock (in dollars per share) | $ / shares $ 54.80    
General and Administrative [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation expense $ 33,000 $ 33,000  
Stock Options [Member]      
Stock Options Activity [Roll Forward]      
Outstanding, beginning of period (in shares) | shares 297,000    
Grants (in shares) | shares 0 0  
Exercised (in shares) | shares (20,000)    
Forfeitures or expirations (in shares) | shares 0    
Outstanding, end of period (in shares) | shares 277,000   297,000
Exercisable, end of period (in shares) | shares 230,750    
Weighted Average Exercise Price [Roll Forward]      
Outstanding, beginning of period (in dollars per share) | $ / shares $ 20.14    
Grants (in dollars per share) | $ / shares 0    
Exercised (in dollars per share) | $ / shares 12.91    
Forfeitures or expirations (in dollars per share) | $ / shares 0    
Outstanding, end of period (in dollars per share) | $ / shares 20.66   $ 20.14
Exercisable, end of period (in dollars per share) | $ / shares $ 18.31    
Weighted Average Remaining Contractual Term [Roll Forward]      
Outstanding 2 years 11 months 26 days   3 years 1 month 6 days
Grants 0 years    
Exercised 0 years    
Forfeitures or expirations 0 years    
Exercisable 2 years 5 months 19 days    
Aggregate Intrinsic Value [Roll Forward]      
Outstanding, beginning of period $ 10,561,380    
Grants 0    
Exercised 0    
Forfeitures or expirations 0    
Outstanding, end of period 9,456,330   $ 10,561,380
Exercisable, end of period 8,420,093    
Additional Disclosures [Abstract]      
Proceeds from stock option exercises 258,250 $ 177,250  
Unrecognized compensation cost $ 234,000    
Recognized compensation period 2 years